Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332

This article from Practical AI discusses the application of machine learning in pharmaceutical drug discovery. It features an interview with Daphne Koller, the co-founder of Coursera and CEO of Insitro. The conversation covers the current state of drug pricing, Insitro's use of ML as a guide in drug discovery, the company's operational model, its focus on the biological aspects of drug discovery, the ML techniques employed, and Koller's perspective on AutoML. The article highlights the potential of AI to revolutionize the pharmaceutical industry.